These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

51 related items for PubMed ID: 9932219

  • 1. Effects of regular insulin or insulin LISPRO on glucose metabolism after an oral glucose load in patients with type 2 diabetes mellitus.
    Paquot N, Roulin D, Schneiter P, Ruiz J, Lefebvre P, Pahud P, Tappy L.
    Diabetes Metab; 1998 Dec; 24(6):523-8. PubMed ID: 9932219
    [Abstract] [Full Text] [Related]

  • 2. A single-center, randomized, double-blind, three-way crossover study examining postchallenge glucose responses to human insulin 70/30 and insulin lispro fixed mixtures 75/25 and 50/50 in patients with type 2 diabetes mellitus.
    Schwartz S, Zagar AJ, Althouse SK, Pinaire JA, Holcombe JH.
    Clin Ther; 2006 Oct; 28(10):1649-57. PubMed ID: 17157120
    [Abstract] [Full Text] [Related]

  • 3. A comparison of preprandial insulin glulisine versus insulin lispro in people with Type 2 diabetes over a 12-h period.
    Luzio S, Peter R, Dunseath GJ, Mustafa L, Owens DR.
    Diabetes Res Clin Pract; 2008 Feb; 79(2):269-75. PubMed ID: 18164094
    [Abstract] [Full Text] [Related]

  • 4. Preprandial combination of lispro and NPH insulin improves overall blood glucose control in type 1 diabetic patients: a multicenter randomized crossover trial.
    Annuzzi G, Del Prato S, Arcari R, Bellomo Damato A, Benzi L, Bruttomesso D, Calderini MC, Coscelli C, Fedele D, Galluzzo A, Giordano M, Giorgino R, Lapolla A, Orsini P, Pagano G, Santoro D, Riccardi G.
    Nutr Metab Cardiovasc Dis; 2001 Jun; 11(3):168-75. PubMed ID: 11590992
    [Abstract] [Full Text] [Related]

  • 5. Premeal insulin lispro plus bedtime NPH or twice-daily NPH in patients with type 2 diabetes: acute postprandial and chronic effects on glycemic control and cardiovascular risk factors.
    Ceriello A, Del Prato S, Bue-Valleskey J, Beattie S, Gates J, de la Peña A, Malone J.
    J Diabetes Complications; 2007 Jun; 21(1):20-7. PubMed ID: 17189870
    [Abstract] [Full Text] [Related]

  • 6. Impact of insulin on microvascular blood flow and endothelial cell function in the postprandial state in patients with Type 1 diabetes.
    Forst T, Forst S, Strunk K, Löbig M, Welter K, Kazda C, Pfützner A.
    J Diabetes Complications; 2005 Jun; 19(3):128-32. PubMed ID: 15866056
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Insulin lispro improves postprandial glucose control in patients with diabetes mellitus.
    Skrha J, Smahelová A, Andĕl M, Vrtovec M, Subić J, Kreze A, Vozar J, Korecová M, de Verga V, Wyatt J, Metcalfe S, Ristić S.
    Sb Lek; 2002 Jun; 103(1):15-21. PubMed ID: 12448933
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A comparative study of insulin lispro and human regular insulin in patients with type 2 diabetes mellitus and secondary failure of oral hypoglycemic agents.
    Ross SA, Zinman B, Campos RV, Strack T, Canadian Lispro Study Group.
    Clin Invest Med; 2001 Dec; 24(6):292-8. PubMed ID: 11767232
    [Abstract] [Full Text] [Related]

  • 15. Insulin glulisine, insulin lispro and regular human insulin show comparable end-organ metabolic effects: an exploratory study.
    Horvath K, Bock G, Regittnig W, Bodenlenz M, Wutte A, Plank J, Magnes C, Sinner F, Fürst-Recktenwald S, Theobald K, Pieber TR.
    Diabetes Obes Metab; 2008 Jun; 10(6):484-91. PubMed ID: 17764465
    [Abstract] [Full Text] [Related]

  • 16. Exenatide: effect of injection time on postprandial glucose in patients with Type 2 diabetes.
    Linnebjerg H, Kothare PA, Skrivanek Z, de la Peña A, Atkins M, Ernest CS, Trautmann ME.
    Diabet Med; 2006 Mar; 23(3):240-5. PubMed ID: 16492205
    [Abstract] [Full Text] [Related]

  • 17. Metabolic effects of mealtime insulin lispro in comparison to glibenclamide in early type 2 diabetes.
    Forst T, Eriksson JW, Strotmann HJ, Bai S, Brunelle R, Gulliya KS, Gack S, Gudat U.
    Exp Clin Endocrinol Diabetes; 2003 Apr; 111(2):97-103. PubMed ID: 12746761
    [Abstract] [Full Text] [Related]

  • 18. Pharmacodynamics of insulin Lispro in 2 patients with type II diabetes mellitus.
    Jehle PM, Fussgänger RD, Seibold A, Lüttke B, Böhm BO.
    Int J Clin Pharmacol Ther; 1996 Nov; 34(11):498-503. PubMed ID: 8937933
    [Abstract] [Full Text] [Related]

  • 19. Optimal dose and timing of insulin Aspart to mimic first phase insulin response in patients with recently onset type 2 diabetes.
    Gredal C, Rosenfalck A, Dejgaard A, Hilsted J.
    Diabetes Res Clin Pract; 2008 May; 80(2):293-8. PubMed ID: 18304675
    [Abstract] [Full Text] [Related]

  • 20. Insulin aspart improves meal time glycaemic control in patients with Type 2 diabetes: a randomized, stratified, double-blind and cross-over trial.
    Perriello G, Pampanelli S, Porcellati F, Avogaro A, Bosi E, Petrella G, Squatrito S, Furneri S, Marra G, Vitali L, Previti M, Cucinotta D.
    Diabet Med; 2005 May; 22(5):606-11. PubMed ID: 15842516
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.